Sign inJoin waitlistJoin the waitlist

Rushad Patell

Associate Program Director, Hematology-Oncology Fellowship · Beth Israel Deaconess Medical Center

Credentials: · · · · · ·

History

Hematology-Oncology Fellowship · Beth Israel Deaconess Medical Center
Present

Hematology and Medical Oncology
Beth Israel Deaconess Medical Center
2014–2017
Internal Medicine
2011–2014
Baroda Medical College
2006–2010

Research

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
Systematic review or meta-analysis · Blood · 2020 · 520 citations
Blood type and outcomes in patients with COVID-19
Annals of Hematology · 2020 · 210 citations
Postdischarge thrombosis and hemorrhage in patients with COVID-19
Blood · 2020 · First of 8 authors · 171 citations

JZ
Jeffrey Zwicker
43 papers
Barbara Lam
11 papers · 8 as a fellow
Deepa Rangachari
11 papers
Jason Freed
11 papers
Alejandra Gutierrez
9 papers · 4 as a fellow
RR
Rachel Rosovsky
9 papers
Jonathan Berry
8 papers
Mary Buss
8 papers
PB
Poorva Bindal
8 papers · 4 as a fellow
Alok Khorana
7 papers
Kenneth Bauer
7 papers
PC
Pavlina Chrysafi
7 papers

Clinical trials

Apixaban in Thrombocytopenia
Principal investigator · Recruiting · Early phase 1
Rushad Patell
2025–2029
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
Principal investigator · Completed · Phase 2
Beth Israel Deaconess Medical Center
2020–2024
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Principal investigator · Completed · Phase 2
Beth Israel Deaconess Medical Center
2018–2024
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Site PI · Recruiting · Phase 3
Anthos Therapeutics, Inc.
2022–2027